Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-14 4:11 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | RA CAPITAL MANAGEMENT L.P. | 2,246,503 7.5% | -81,211 (-3.49%) | View |
2022-02-14 08:03 am Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW INVESTMENTS LP | 4,315,102 14.4% | -99 (-0.00%) | View |
2022-02-11 4:32 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 2,583,821 8.7% | 90,712 (+3.64%) | View |
2021-02-16 4:57 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Boxer Capital LLC | 2,477,194 8.3% | 700,000 (+39.39%) | View |
2021-02-16 4:39 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | RA CAPITAL MANAGEMENT L.P. | 2,327,714 7.8% | 2,327,714 (New Position) | View |
2021-02-16 12:24 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | PRICE T ROWE ASSOCIATES INC | 374,957 1.2% | -911,550 (-70.85%) | View |
2021-02-16 06:10 am Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Forbion Capital Fund III Cooperatief U.A. | 0 0% | -1,303,902 (Position Closed) | View |
2021-02-12 5:03 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | ORBIMED CAPITAL LLC | 2,493,109 8.36% | 2,493,109 (New Position) | View |
2021-02-12 09:28 am Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW INVESTMENTS LP | 4,315,201 14.46% | 356,937 (+9.02%) | View |
2021-02-11 7:10 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 1,387,393 4.7% | -1,332,917 (-49.00%) | View |
2021-01-20 6:33 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Domain Partners VIII L.P. | 860,724 2.9% | -1,012,381 (-54.05%) | View |
2021-01-11 5:25 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Ikarian Capital LLC | 1,836,545 6.2% | 1,836,545 (New Position) | View |
2020-08-03 4:31 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Boxer Capital LLC | 1,777,194 7.2% | 1,777,194 (New Position) | View |
2020-04-03 4:05 pm Sale | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners II L.P. | 0 0% | -2,215,089 (Position Closed) | View |
2020-03-12 1:11 pm Sale | 13D | MILESTONE PHARMACEUTICALS INC MIST | Novo Holdings A/S | 2,080,885 8.47% | -353,585 (-14.52%) | View |
2020-02-14 4:08 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners II L.P. | 2,215,089 9% | 2,215,089 (New Position) | View |
2020-02-14 1:44 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | RTW INVESTMENTS LP | 3,958,264 16.16% | 436,408 (+12.39%) | View |
2020-02-14 1:30 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | PRICE T ROWE ASSOCIATES INC | 1,286,507 5.2% | 1,286,507 (New Position) | View |
2020-02-11 5:04 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Forbion Capital Fund III Cooperatief U.A. | 1,303,902 5.3% | 1,303,902 (New Position) | View |
2020-01-09 5:18 pm Purchase | 13G | MILESTONE PHARMACEUTICALS INC MIST | Domain Partners VIII L.P. | 1,873,105 7.6% | 1,873,105 (New Position) | View |